PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Tirzepatide
Presentation Product Chemical substance Chapter Items dispensed
Tirzepatide 5mg/0.6ml inj 2.4ml pf dispos dev
0601023AZAAAGAG
Tirzepatide Tirzepatide Endocrine System 35,918
Tirzepatide 2.5mg/0.6ml inj 2.4ml pf dispos dev
0601023AZAAAHAH
Tirzepatide Tirzepatide Endocrine System 19,430
Tirzepatide 7.5mg/0.6ml inj 2.4ml pf dispos dev
0601023AZAAACAC
Tirzepatide Tirzepatide Endocrine System 9,975
Tirzepatide 10mg/0.6ml inj 2.4ml pf dispos dev
0601023AZAAAFAF
Tirzepatide Tirzepatide Endocrine System 5,564
Tirzepatide 12.5mg/0.6ml inj 2.4ml pf dispos dev
0601023AZAAAEAE
Tirzepatide Tirzepatide Endocrine System 1,446
Tirzepatide 15mg/0.6ml inj 2.4ml pf dispos dev
0601023AZAAADAD
Tirzepatide Tirzepatide Endocrine System 1,328
Tirzepatide 2.5mg/0.5ml inj pre-filled disposable devices
0601023AZAAAAAA
Tirzepatide Tirzepatide Endocrine System 28
Tirzepatide 5mg/0.5ml inj pre-filled disposable devices
0601023AZAAABAB
Tirzepatide Tirzepatide Endocrine System 25

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.